Subscribe
Subscribe

  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Mithra Signs Deal with Fuji Pharma for Donesta in Asia

9.36 million euros for the Bio Base Europe Pilot Plant

Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference

Belgium again attends the BIO International Convention 2017 with a stunning 74 companies and organizations and 135 delegates on one of the most vibrant pavilions at the conference. The Belgian delegation comes together in one of the most vibrant pavilions at the conference. 

Ablynx appoints Markus Ewert as Chief Business Officer

Biocartis launches CE-marked IVD test for lung cancer

Delphi Genetics receives GMP accreditation for plasmid DNA bioproduction

Genetic engineering specialist Delphi Genetics announced that it has received the certificate of Good Manufacturing Practice (GMP) for plasmid DNA production. The GMP productions will be realized in clean rooms located in Delphi Genetics’ own facilities. Furthermore, the GMP facilities will benefit from the company's 'Antibiotic Free" Technology.

IDO 1: a promising new target for immunotherapy

Immunotherapy: a paradigm shift in cancer treatment

An excerpt from the BioVox White paper on Cancer Immunotherapy.

Lars Klareskog pushes rheumatology beyond symptomatic treatment

Over the years, the perception of inflammatory diseases has changed drastically. The advent of cytokine inhibitors meant great improvement to many patients, especially those suffering from rheumatoid arthritis. However, these treatments remain symptomatic. Together with Janssen Pharmaceutica, world-renowned rheumatologist Lars Klareskog is ready to take the research and treatment of inflammatory joint disease to the next level.

KWS and Bayer grant first license for herbicide-tolerant sugarbeet to SESVanderHave

KWS SAAT SE and Bayer AG have given access to a long-term license for their new CONVISO®SMART cultivation system for sugarbeet to the Belgian sugarbeet seed breeding company SESVanderHave. The technology is based on the breeding of sugarbeet varieties that are tolerant to herbicides in the ALS inhibitor class with broad-spectrum weed control.

  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Mithra Signs Deal with Fuji Pharma for Donesta in Asia

9.36 million euros for the Bio Base Europe Pilot Plant

Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference

Belgium again attends the BIO International Convention 2017 with a stunning 74 companies and organizations and 135 delegates on one of the most vibrant pavilions at the conference. The Belgian delegation comes together in one of the most vibrant pavilions at the conference. 

Ablynx appoints Markus Ewert as Chief Business Officer

Biocartis launches CE-marked IVD test for lung cancer

Delphi Genetics receives GMP accreditation for plasmid DNA bioproduction

Genetic engineering specialist Delphi Genetics announced that it has received the certificate of Good Manufacturing Practice (GMP) for plasmid DNA production. The GMP productions will be realized in clean rooms located in Delphi Genetics’ own facilities. Furthermore, the GMP facilities will benefit from the company's 'Antibiotic Free" Technology.

IDO 1: a promising new target for immunotherapy

Immunotherapy: a paradigm shift in cancer treatment

An excerpt from the BioVox White paper on Cancer Immunotherapy.

Lars Klareskog pushes rheumatology beyond symptomatic treatment

Over the years, the perception of inflammatory diseases has changed drastically. The advent of cytokine inhibitors meant great improvement to many patients, especially those suffering from rheumatoid arthritis. However, these treatments remain symptomatic. Together with Janssen Pharmaceutica, world-renowned rheumatologist Lars Klareskog is ready to take the research and treatment of inflammatory joint disease to the next level.

KWS and Bayer grant first license for herbicide-tolerant sugarbeet to SESVanderHave

KWS SAAT SE and Bayer AG have given access to a long-term license for their new CONVISO®SMART cultivation system for sugarbeet to the Belgian sugarbeet seed breeding company SESVanderHave. The technology is based on the breeding of sugarbeet varieties that are tolerant to herbicides in the ALS inhibitor class with broad-spectrum weed control.